SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-299651"
 

Search: onr:"swepub:oai:DiVA.org:uu-299651" > Mechanisms and cons...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Mechanisms and consequences of bacterial resistance to antimicrobial peptides

Andersson, Dan I. (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
Hughes, Diarmaid (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
Kubicek-Sutherland, Jessica Z. (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
 (creator_code:org_t)
Elsevier BV, 2016
2016
English.
In: Drug resistance updates. - : Elsevier BV. - 1368-7646 .- 1532-2084. ; 26, s. 43-57
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Cationic antimicrobial peptides (AMPs) are an intrinsic part of the human innate immune system. Over 100 different human AMPs are known to exhibit broad-spectrum antibacterial activity. Because of the increased frequency of resistance to conventional antibiotics there is an interest in developing AMPs as an alternative antibacterial therapy. Several cationic peptides that are derivatives of AMPs from the human innate immune system are currently in clinical development. There are also ongoing clinical studies aimed at modulating the expression of AMPs to boost the human innate immune response. In this review we discuss the potential problems associated with these therapeutic approaches. There is considerable experimental data describing mechanisms by which bacteria can develop resistance to AMPs. As for any type of drug resistance, the rate by which AMP resistance would emerge and spread in a population of bacteria in a natural setting will be determined by a complex interplay of several different factors, including the mutation supply rate, the fitness of the resistant mutant at different AMP concentrations, and the strength of the selective pressure. Several studies have already shown that AMP-resistant bacterial mutants display broad cross-resistance to a variety of AMPs with different structures and modes of action. Therefore, routine clinical administration of AMPs to treat bacterial infections may select for resistant bacterial pathogens capable of better evading the innate immune system. The ramifications of therapeutic levels of exposure on the development of AMP resistance and bacterial pathogenesis are not yet understood. This is something that needs to be carefully studied and monitored if AMPs are used in clinical settings.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Keyword

Antimicrobial peptides
Anti-bacterial drugs
Resistance
Innate immunity
Selection
Bacterial infections

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Andersson, Dan I ...
Hughes, Diarmaid
Kubicek-Sutherla ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Pharmaceutical S ...
Articles in the publication
Drug resistance ...
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view